Variant report

Variant	rs35042045
Chromosome Location	chr7:116598724-116598725
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:3)
CpG islands
(count:0)
Chromatin interactive
region (count:2)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:3 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	MAX	chr7:116598609-116598728	GM12878	blood:	n/a	n/a
2	WRNIP1	chr7:116598641-116598729	GM12878	blood:	n/a	n/a
3	ARID3A	chr7:116598666-116598759	K562	blood:	n/a	n/a

No data

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr7:116592155..116595657-chr7:116596511..116599037,5	MCF-7	breast:
2	chr7:116589691..116599368-chr7:116647062..116658963,30	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CAPZA2-2	chr7:116598643-116598739	NONHSAT122916

No data

Variant related genes	Relation type
ST7-AS1	TF binding region
ENSG00000214188	Chromatin interaction
ENSG00000004866	Chromatin interaction
ENSG00000227199	Chromatin interaction

Extended variants
information (count: 20 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:16)

rs_ID	r²[population]
rs10230431	0.97[EUR][1000 genomes]
rs10260368	0.82[ASN][1000 genomes]
rs17139184	0.96[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs17139270	0.91[AFR][1000 genomes];0.89[AMR][1000 genomes];0.93[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs2428284	0.82[ASN][1000 genomes]
rs2428286	0.82[ASN][1000 genomes]
rs2428289	0.91[AFR][1000 genomes];0.89[AMR][1000 genomes];0.93[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs2429032	0.90[EUR][1000 genomes];0.85[ASN][1000 genomes]
rs2429044	0.82[ASN][1000 genomes]
rs4074503	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs4489259	0.86[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs57283107	0.95[EUR][1000 genomes]
rs61673738	0.92[EUR][1000 genomes]
rs61690499	0.97[EUR][1000 genomes]
rs6466595	0.97[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6963873	0.85[EUR][1000 genomes];0.80[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:4 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv831107	chr7:116414734-116649466	Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	45 gene(s)	inside rSNPs	diseases
2	nsv889074	chr7:116552859-116604194	Weak transcription Active TSS Flanking Active TSS Enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
3	nsv889075	chr7:116552859-116610237	Weak transcription Enhancers Active TSS Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	29 gene(s)	inside rSNPs	diseases
4	nsv889073	chr7:116552859-116611113	Weak transcription Active TSS Strong transcription Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:44 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:116594800-116600200	Weak transcription	Lung	lung
2	chr7:116595000-116608600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
3	chr7:116595200-116600200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr7:116595200-116621600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr7:116595400-116608600	Weak transcription	HSMM	muscle
6	chr7:116595600-116602800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr7:116595600-116617200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr7:116596200-116598800	Flanking Active TSS	GM12878-XiMat	blood
9	chr7:116596200-116601000	Weak transcription	NHEK	skin
10	chr7:116596400-116599800	Weak transcription	NHLF	lung
11	chr7:116596400-116616600	Weak transcription	Osteobl	bone
12	chr7:116596400-116622200	Weak transcription	Fetal Intestine Large	intestine
13	chr7:116596600-116600800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
14	chr7:116596600-116606600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
15	chr7:116596600-116606800	Weak transcription	Hela-S3	cervix
16	chr7:116596600-116612000	Weak transcription	Fetal Intestine Small	intestine
17	chr7:116596600-116617400	Weak transcription	Fetal Muscle Leg	muscle
18	chr7:116596800-116603600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
19	chr7:116596800-116606200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
20	chr7:116596800-116606800	Weak transcription	Psoas Muscle	Psoas
21	chr7:116596800-116607200	Weak transcription	Brain Hippocampus Middle	brain
22	chr7:116596800-116609600	Weak transcription	Right Atrium	heart
23	chr7:116596800-116609600	Weak transcription	Skeletal Muscle Female	skeletal muscle
24	chr7:116596800-116617200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
25	chr7:116597000-116599600	Enhancers	K562	blood
26	chr7:116597000-116641600	Weak transcription	Ovary	ovary
27	chr7:116597200-116602400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
28	chr7:116597200-116602800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr7:116597200-116610000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr7:116597800-116599000	Enhancers	iPS-15b Cell Line	embryonic stem cell
31	chr7:116597800-116610200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr7:116598000-116598800	Enhancers	H1 Cell Line	embryonic stem cell
33	chr7:116598000-116598800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
34	chr7:116598200-116598800	Enhancers	Aorta	Aorta
35	chr7:116598200-116598800	Enhancers	Left Ventricle	heart
36	chr7:116598200-116599200	Enhancers	HUES48 Cell Line	embryonic stem cell
37	chr7:116598200-116607400	Weak transcription	H9 Cell Line	embryonic stem cell
38	chr7:116598400-116610400	Weak transcription	HepG2	liver
39	chr7:116598400-116617600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr7:116598600-116598800	Enhancers	Brain Inferior Temporal Lobe	brain
41	chr7:116598600-116598800	Enhancers	Pancreas	Pancrea
42	chr7:116598600-116599200	Enhancers	HUES64 Cell Line	embryonic stem cell
43	chr7:116598600-116599200	Enhancers	Right Ventricle	heart
44	chr7:116598600-116599600	Enhancers	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links